Tesla owner lawsuit claims software update fraudulently cut battery capacity
August 8, 2019
South Korea boycott hitting sales of Japan’s Uniqlo, company says
August 9, 2019

Sarepta says adverse event report for DMD gene therapy erroneously submitted

Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to the U.S. health regulator regarding an ongoing study of the company’s gene therapy for Duchenne muscular dystrophy (DMD).

Powered by WPeMatico